top of page

ENGINEERING HOPE FOR ADULTS AND CHILDREN WITH LIVER DISEASE

Our mission is to transform the treatment of liver disease

ReLiver: Morphocell's engineered tissue simply explained in its future potential to treat liver disease.

Video powered by Life Science Animation

Our Solution: ReLiver

®

Using advanced tissue engineering, we’re developing the world’s first effective treatments for the most dire liver diseases

UPDATES

Morphocell Technologies Appoints Dr. Paul K. Wotton to the Board of Directors

Renowned Biotech Leader Dr. Vincent Ling Joins Morphocell Technologies as Chief Business Officer

Marc Courtois_portrait.jpg

Morphocell Technologies appoints Marc Courtois to Board of Directors

DidierLeconteHR Vertical_edited.jpg

Morphocell Technologies appoints Didier Leconte as an independent member of its Board of Directors

Morphocell Technologies welcomes Patrick Bedford as Vice President of Regulatory Affairs

Morphocell Technologies Announces Completion of US$40 Million Series A Financing to Transform the Treatment of Liver Disease

bottom of page